Bio
Phil Gutry joined MPM's San Francisco office as a Principal in 2011. He previously worked for five years in Corporate Development at Gilead Sciences where he focused on M&A and licensing in antiviral, respiratory, and liver disease. His deal experience includes Gilead's acquisition of Arresto Biosciences and partnership with MicroDose Therapeutx. Prior to Gilead, Phil was a Principal at Riverside Partners where he spent six years focused on private equity investments in life science instrumentation, diagnostics, and medical products companies. Phil began his career with The Wilkerson Group, a healthcare focused consulting firm. Phil holds an M.B.A. from The Wharton School and an A.B. from Dartmouth College.
Career
|
MPM CapitalEmail: [email protected] |